Portfolio

MI-Hip

MI-Hip is commercializing simulators to teach physicians how to properly diagnose hip dysplasia in newborns.
(2025)

Modal Mobility

Commercializing a SaaS solution to supplement existing fixed route rail and bus with on-demand shuttles. Helping to solve the “first-mile/last-mile problem” in modal transportation.
(2025)

NanoOnco

NanoOnco is developing a bioabsorbable magnesium device designed to control cancer and cancer metastasis.
(2025)

Nytricx

Nytricx is developing a product using nitric oxide to prevent infection and clotting with catheters and other devices.
(2025)

Ocutheia

Ocutheia is developing a small molecule as monotherapy for dry and wet age-related macular degeneration.
(2025)

Probetruth

ProbeTruth is a cybersecurity AI company dedicated to protecting the integrity of audio, video and image media. The company has developed an advanced anti-deepfake technology and Deep Forgery Detector (DFD) that leverage multimodal and neurosymbolic AI.
(2025)

Recens Medical

Rapid precision medical cooling.
(2025)

Rewind

Rewind is a proven clinical program that targets the fundamentals of metabolic disease: biology and lifestyle to fight type 2 diabetes.
(2025)

Roadmap Learning

Roadmap Learning is commercializing educational technology for interactive and collaborative classroom learning.
(2025)

SaferDrive AI

Developing applications, simulations, frameworks, and other software components for testing and training autonomous vehicles.
(2025)

Sequestro

Sequestro is developing a novel cellulose-based adsorbent that effectively removes PFASs from water.
(2025)

Sidescope

Sidescope is bringing to market AI-driven ophthalmic surgical decisions support systems based on the research of Dr. Nambi Nallasamy in Michigan Medicine.
(2025)

SignetRisk

SignetRisk is developing the next generation of cyber risk data and analysis capabilities to power the rapidly growing cyber risk quantification and management market.
(2025)

Supercritical

Supercritical is commercializing software that optimizes airfoil designs.
(2025)

Syntheos

Developing tools to assist with the evaluation of early stage innovations.
(2025)

Volt Harbor

Volt Harbor is developing a technology to enable second-life batteries for energy storage and peak power stabilizing applications.
(2025)

ALLInBio, Inc.

Therapeutics for rheumatoid arthritis and potentially other autoimmune disorders.
(2024)

ArtSpective

ArtSpective™ is research-tested and effective implicit bias training program built on neuroscience and museum-based pedagogy.
(2024)